Skip to main content
Clinical Trials/NCT03505541
NCT03505541CompletedNot Applicable

Effect of Adiponectin and TNFa on Uterine Contractility in GDM and Obese Pregnant Patients

University of Minnesota1 site in 1 country60 target enrollmentStarted: August 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Effect on force of contractility

Study Overview

Brief Summary

Investigate the effect of two adipokines which are adiponectin and TNFa on the force of myometrial contractility in diabetic, non-obese pregnant women and obese, non-diabetic term pregnant women at the time of scheduled cesarean delivery

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pregnant patients scheduled for a CS at 37-41 weeks of gestation at M Health Birth Place
  • Participants age ≥
  • Full informed consent able to be provided by the participant.

Exclusion Criteria

  • Patients undergoing general anesthesia for their CS.
  • Pre-gestational DM, and DM diagnosed <24 weeks gestation.
  • Patients unable to consent for themselves
  • Multiple gestation

Outcomes

Primary Outcomes

Effect on force of contractility

Time Frame: 24 hours

Determine the effect of adiponectin and TNFa on the force of myometrial contractility in diabetic, non-obese pregnant women and obese, non-diabetic term pregnant women at the time of scheduled cesarean delivery

Secondary Outcomes

  • Progesterone effect in control group(24 hours)
  • Force of contractility between study groups(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Adipokines Effect in Myometrial... | Clinical Trial